AI-generated from publicly available materials.Samsung Electronics has received FDA clearance for new software features that enable its Galaxy Buds to function as an over-the-counter (OTC) hearing aid, including a diagnostic hearing test capability.
The new software, classified as a medical device, delivers medical-grade results, as noted in a recent press release. This development is particularly significant given the World Health Organization's projection that the number of individuals experiencing hearing loss globally will rise from 1.5 billion to 2.5 billion by 2050. Samsung aims to enhance accessibility to hearing support through this integration, allowing users to conduct a comprehensive hearing test directly via the Galaxy Buds without needing a separate application.
Samsung's journey in this domain began with the introduction of personal sound amplification features in its Galaxy Buds+ in 2020, which underwent clinical validation the following year. The latest features were developed in partnership with the National Acoustic Laboratories in Australia and the Samsung Medical Center in Seoul, with validation from several U.S. institutions, including Vanderbilt University Medical Center.
This FDA clearance is part of a broader trend, as the agency has recently approved similar technologies, including Apple's AirPods, marking a significant shift towards prescription-free hearing solutions. The anticipated rollout of these features in the U.S. and select markets by the year's end could democratize access to hearing aids, making proactive hearing care more manageable for millions.